Navigation Links
Globus Medical Announces Record 2nd Quarter 2007 Results
Date:8/27/2007

AUDUBON, Pa., Aug. 27 /PRNewswire/ -- Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced record revenue for the quarter ending June 30, 2007. The company recorded revenues of $30.2 million for the second quarter -- an increase of 52% over the $19.9 million it achieved in the same quarter a year ago. The announcement follows on the heels of $110 million in series E financing to fund Globus' continued rapid growth.

"The record results were driven by a major expansion of the company's sales and distribution footprint, and the introduction of several new products across its fusion, MIS and biomaterials portfolio," said Rick Kienzle, Executive Vice President of Sales and Marketing, Globus Medical. "In addition, strong market acceptance of our Revere(TM) pedicle screw system continues to fuel significant conversions in our established and new markets."

During the second quarter, Globus Medical added several highly-experienced sales professionals in key U.S. markets, bringing the total number of people added to its sales and distribution infrastructure in 2007 to 25.

So far in 2007, Globus has introduced six new systems that represent significant technological advancements in fusion, MIS and biomaterials. Additionally, in the area of motion preservation, the company announced two "world's first" surgeries using its transforaminal and posterior disc replacement systems.

Globus Medical also entered the biomaterial segment during the second quarter with the introduction of the NuBone(TM) Osteoinductive Bone Graft Product Line, the first of several new biomaterial initiatives planned for the next 12 months. The launch of Globus Medical's MARS(TM) Minimally Invasive Retractor System filled out its MIS product portfolio, further securing the company's leadership position in MIS technology and products. Both MIS and biomaterials are key initiatives in Globus Medical's strategy to innovate acros
'/>"/>

SOURCE Globus Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The New York investment bank ...SX:NEU) has agreed an AU$6.7 mil convertible note ...or. The private placement was arranged by KTA Capi...sor. , New York (PRWEB) N...tment bank KTA Capital, LLC ("KTA Capital&quo...
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced that it has re...ading in the company,s common stock will be,suspen... be filed with the,Securities and Exchange Commiss...listing on Nasdaq, unless the company files an app...
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novemb...nc. (Nasdaq: DCGN ) today announced the approval o...uptcy Court for the District of Delaware,(the "Ban...y petition for,relief under Chapter 11 of the Unit...t. , The orders issued by the Bankruptcy ...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia...Food & Drug Administration (SFDA) has approved...r its oral insulin project,(Nodlin), an innovative...pproval allows Biolaxy to initiate its first phase...er characteristic of high blood glucose and poor,m...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2
...Calif., April 23 STAAR Surgical,Company (Nasdaq: ...keter of,minimally invasive ophthalmic products, t...rst of its nine-part webinar series on the Company... first session which aired,Tuesday, April 22, 2008...Me," is part of a new marketing initiative designe...
...weden and CAMBRIDGE, England, April 23 Two,leadin...covery (FBDD) today,announced a new commercial all...e, UK, and Beactica AB, based in Uppsala, Sweden, ...d lead discovery and optimization,platform., The ...-directed FBDD,libraries to state-of-the-art fragm...
...PS Increased 22 Percent, CAMBRIDGE, Mass., April ...orted results for the first quarter of,2008, which...ating,leverage, a significant increase in non-GAAP... First-Quarter Highlights -- Total revenue for t... $883.2 million in same period a year ago. This ...
Other Biology Technology:More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch 2More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch 3New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden) 2Genzyme Reports Strong First-Quarter Growth 2Genzyme Reports Strong First-Quarter Growth 3Genzyme Reports Strong First-Quarter Growth 4Genzyme Reports Strong First-Quarter Growth 5Genzyme Reports Strong First-Quarter Growth 6Genzyme Reports Strong First-Quarter Growth 7Genzyme Reports Strong First-Quarter Growth 8Genzyme Reports Strong First-Quarter Growth 9Genzyme Reports Strong First-Quarter Growth 10Genzyme Reports Strong First-Quarter Growth 11Genzyme Reports Strong First-Quarter Growth 12Genzyme Reports Strong First-Quarter Growth 13Genzyme Reports Strong First-Quarter Growth 14Genzyme Reports Strong First-Quarter Growth 15Genzyme Reports Strong First-Quarter Growth 16Genzyme Reports Strong First-Quarter Growth 17Genzyme Reports Strong First-Quarter Growth 18Genzyme Reports Strong First-Quarter Growth 19
(Date:11/24/2009)...te (LRI) today named 12 new grant recipients for 2...innovative work across a broad spectrum of lupus r...ovelty, and potential to drive scientific discover...ex disease of systemic lupus. , The 2009 grants ...cross the nation and include interdisciplinary and...
(Date:11/24/2009)...and flabby arteries from collapsing have been true...re no longer needed -- once the arteries are stren...ors had no choice but to leave them in place. , ...partment of Biomedical Engineering has developed a...ugs where they,re needed, then dissolves. , "Our...
(Date:11/24/2009)...November 24, 2009) -- The Wildlife Conservation So...t the last remaining population of Siberian tigers...ng tide of poaching and habitat loss. , ...fficials of what needs to be done to protect remai... The report was released by the Siberia...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2Supplement Might Help Compulsive Hair Pullers 50970 1Supplement Might Help Compulsive Hair Pullers 50970 2King Provides Additional Information on the REMOXY 28R 29 NDA Resubmission Plan 50967 1King Provides Additional Information on the REMOXY 28R 29 NDA Resubmission Plan 50967 2World Financial Crisis and AIDS Backlash Threaten Lives 50964 1World Financial Crisis and AIDS Backlash Threaten Lives 50964 2World Financial Crisis and AIDS Backlash Threaten Lives 50964 3
...ia (Oct. 17, 2007) The Nature Conservancy and Con...nments of the United States and Costa Rica in one ... The agreement will ensure the protection of Cost...s, with the United States forgiving $26 million of...unt on tropical forest conservation programs over ...
...s have been identified in 47-million year old lake...nus Anacardium was once distributed in Europe, rem... and South America. It was previously proposed tha...ra, diverged from their common ancestor when the l...owever, groundbreaking new data in the October iss...
...e University of Rochester believe they have just c...X chromosome is a strikingly powerful force in the...r years whether the X chromosomethe female chromos...cess of speciation. In a new study in the journal ...gy at the University of Rochester, has confirmed t...
Other Biology News:Costa Rica, US announce historic debt-for-nature swap 2Costa Rica, US announce historic debt-for-nature swap 3Fossilized cashew nuts reveal Europe was important route between Africa and South America 2X-effect: female chromosome confirmed a prime driver of speciation 2
...X Fernbach-style culture flask is designed for cul... volume ratio. It can also be used in serum produc...o achieve maximal oxygen transfer to culture mediu...accepts cotton plugs or No. 13 rubber stoppers. Th...
...emplate is designed to allow neomycin/kanamycin se...FRT-PGK-gb2-neo-FRT template encodes the neomycin/...otic promoter (gb2) for expression of kanamycin re...GK) for expression of neomycin resistance in mamma...
Corning disposable NMR tube caps, 5mm from Sigma-Aldrich
...r, 7 inch long PYREX NMR tubes are made from quali...d joints, valves, and vacuum racks. They are desig...to 500MHz. They have an O.D. of 4.97 + 0.000-0.013...tubes can be used with the PYREX Microcell system ...
Biology Products: